Human visceral leishmaniasis expresses Th1 pattern in situ liver lesions.
The architectural and infiltrate pattern of liver human visceral leishmaniasis (HVL) have been systematically classified as typical, fibrogenic or nodular. Despite this histopathological classification, the immune response based on cytokines and cellular phenotypes have never been performed. The aim of this study was to determine the immunophenotypic pattern and cytokine profile of the nodular involvement of the liver in HVL. We evaluated nine cases of the nodular form of HVL. In situ immune response was studied through cytokine analysis and immunohistochemical study for phenotype markers: IL-1, IL-4, IL-10, TNF-alpha, IFN-gamma, CD4+ T cells, CD8+ T cells, CD20, CD68, CD57 and macrophage activation was determined by evaluation of iNOS activity. HVL seems to be related to a better immune response. Amastigotes were rarely found on liver sections. Leishmania antigen expression was also rare and located in the inflammatory nodules. The lower expression of IL-4 and IL-10, moderate expression of TNF-alpha and IFN-gamma demonstrate a panorama of Th1 phenotype. The increased expression of NK cells could help in sustaining this model of response. This pattern of immune response is probably responsible for improvement in the parasite's clearance from liver tissue and it is a prognostic marker of human visceral leishmaniasis.
Seixas Duarte
Maria Irma
MI
Laboratory of Infectious Diseases Pathology, Pathology Department, Faculty of Medical Sciences, University of Sao Paulo, Sao Paulo, Brazil. miduarte@usp.br
Tuon
Felipe Francisco
FF
Pagliari
Carla
C
Kauffman
Monica R
MR
Brasil
Roosecelis Araujo
RA
D000818:Animals; D000953:Antigens, Protozoan / Q000032:analysis / Q000276:immunology; D016207:Cytokines / Q000378:metabolism; D006801:Humans; D007150:Immunohistochemistry; D016130:Immunophenotyping; D007694:Killer Cells, Natural / Q000276:immunology; D007891:Leishmania / Q000276:immunology* / Q000302:isolation & purification / Q000472:pathogenicity; D007898:Leishmaniasis, Visceral / Q000276:immunology* / Q000469:parasitology / Q000473:pathology; D008099:Liver / Q000276:immunology* / Q000469:parasitology / Q000473:pathology*; D018417:Th1 Cells / Q000276:immunology*
D000953:Antigens, Protozoan; D016207:Cytokines